Medicare Enrolled
Dr. Pavel Levin, M.D., PH.D.
Student in an Organized Health Care Education/Training Program · Pearland, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Levin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Levin
Dr. Pavel Levin is a student in an organized health care education/training program specialist in Pearland, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Levin performed 12,593 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Levin received a total of $23,817 from 67 pharmaceutical and/or device companies across 490 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Levin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 1% volume in TX
$23,817 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,593
Medicare services
Top 1% in TX for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,690 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
698 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
653 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
469 | $10 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $67 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $96 | $368 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
144 | $60 | $247 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
64 | $23 | $157 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
51 | $11 | $96 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
49 | $94 | $470 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
48 | $102 | $707 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
46 | $6 | $31 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $132 | $565 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
31 | $134 | $496 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
29 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
29 | $6 | $34 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $128 | $694 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
28 | $51 | $313 |
| New patient office visit, complex (60-74 min) | 14 | $162 | $709 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
78.1% high complexity
0.4% medium
21.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$23,817
Total received (2018-2024)
Avg $3,402/year across 7 years
Top 2% in TX for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
490
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$10,365
2023
$4,086
2022
$4,692
2021
$212
2020
$176
2019
$4,035
2018
$252
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$3,042
BeiGene USA, Inc.
$2,275
Novartis Pharmaceuticals Corporation
$1,336
PFIZER INC.
$403
Merck Sharp & Dohme LLC
$378
Celgene Corporation
$247
E.R. Squibb & Sons, L.L.C.
$223
ABBVIE INC.
$184
Janssen Biotech, Inc.
$162
GENZYME CORPORATION
$155
Takeda Pharmaceuticals U.S.A., Inc.
$154
Daiichi Sankyo Inc.
$152
Gilead Sciences, Inc.
$146
Astellas Pharma US Inc
$137
Alexion Pharmaceuticals, Inc.
$103
GlaxoSmithKline, LLC.
$96
SOBI, INC
$94
PUMA BIOTECHNOLOGY, INC.
$78
Genentech USA, Inc.
$74
Rigel Pharmaceuticals, Inc.
$65
Regeneron Healthcare Solutions, Inc.
$63
Deciphera Pharmaceuticals Inc.
$60
Karyopharm Therapeutics Inc.
$59
Exelixis Inc.
$52
Lilly USA, LLC
$51
Incyte Corporation
$50
ARRAY BIOPHARMA INC
$49
TAIHO ONCOLOGY, INC.
$49
Tempus AI, Inc
$43
Eisai Inc.
$37
EMD Serono, Inc.
$32
Adaptive Biotechnologies Corporation
$30
TerSera Therapeutics LLC
$30
SpringWorks Therapeutics, Inc.
$30
Bayer Healthcare Pharmaceuticals Inc.
$30
PharmaEssentia USA Corporation
$26
Janssen Pharmaceuticals, Inc
$26
SERVIER PHARMACEUTICALS LLC
$25
ADC Therapeutics America, Inc.
$23
Boston Scientific Corporation
$23
Stemline Therapeutics Inc.
$22
Aveo Pharmaceuticals, Inc.
$18
Amgen Inc.
$18
Amneal Pharmaceuticals LLC
$17
Top 3 companies account for 64.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$7,396
Alexion Pharmaceuticals, Inc.
$3,303
BeiGene USA, Inc.
$2,363
Novartis Pharmaceuticals Corporation
$1,692
PFIZER INC.
$963
Merck Sharp & Dohme LLC
$669
Janssen Biotech, Inc.
$537
E.R. Squibb & Sons, L.L.C.
$510
Celgene Corporation
$482
GENZYME CORPORATION
$412
Daiichi Sankyo Inc.
$400
Astellas Pharma US Inc
$380
Takeda Pharmaceuticals U.S.A., Inc.
$298
Gilead Sciences, Inc.
$283
Seagen Inc.
$276
Lilly USA, LLC
$254
ABBVIE INC.
$243
Amgen Inc.
$221
Genentech USA, Inc.
$176
Karyopharm Therapeutics Inc.
$173
TerSera Therapeutics LLC
$165
AVEO Pharmaceuticals, Inc.
$159
Incyte Corporation
$145
Eisai Inc.
$144
SOBI, INC
$126
GlaxoSmithKline, LLC.
$122
SERVIER PHARMACEUTICALS LLC
$121
Rigel Pharmaceuticals, Inc.
$120
TAIHO ONCOLOGY, INC.
$110
PharmaEssentia USA Corporation
$109
PUMA BIOTECHNOLOGY, INC.
$103
CTI BioPharma Corp.
$84
Puma Biotechnology, Inc.
$82
Exelixis Inc.
$82
Pharming Healthcare, Inc.
$78
ARRAY BIOPHARMA INC
$74
Regeneron Healthcare Solutions, Inc.
$63
Deciphera Pharmaceuticals Inc.
$60
Bayer Healthcare Pharmaceuticals Inc.
$53
Boston Scientific Corporation
$51
Stemline Therapeutics Inc.
$47
MorphoSys, US Inc.
$46
Tempus AI, Inc
$43
JAZZ PHARMACEUTICALS INC.
$42
Kyowa Kirin, Inc.
$38
Global Blood Therapeutics, Inc.
$35
Pharmacyclics LLC, An AbbVie Company
$35
EMD Serono, Inc.
$32
Pharmacosmos Therapeutics Inc.
$31
EISAI INC.
$31
Apellis Pharmaceuticals, Inc.
$30
Adaptive Biotechnologies Corporation
$30
SpringWorks Therapeutics, Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
Janssen Pharmaceuticals, Inc
$26
Sirtex Medical Inc
$25
ADC Therapeutics America, Inc.
$23
Sobi, Inc
$22
Chiesi USA, Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$18
Kite Pharma, Inc.
$18
Aveo Pharmaceuticals, Inc.
$18
Sumitomo Pharma America, Inc.
$17
Amneal Pharmaceuticals LLC
$17
Taiho Oncology, Inc.
$13
Acrotech Biopharma LLC
$12
Myriad Genetic Laboratories, Inc.
$12
Top 3 companies account for 54.8% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · Alecensa · BELEODAQ · BESREMI · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CAMZYOS · CARVYKTI · CYRAMZA · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · FERRIPROX · FOTIVDA · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RUCONEST · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SYNAGIS · Stivarga · TABRECTA · TALZENNA · TECVAYLI · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Vectibix · Venclexta · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xermelo · Xospata · Xtandi · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
4,965
County median income
$95,155
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Levin is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Levin experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Levin performed 9,690 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Levin receive payments from pharmaceutical companies?
Yes. Dr. Levin received a total of $23,817 from 67 companies across 490 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levin's costs compare to other student in an organized health care education/training programs in Pearland?
Dr. Levin's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Pearland
Browse student in an organized health care education/training programs in Pearland ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in TX
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in TX
Which TX student in an organized health care education/training programs receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology